Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS2 | P35354 | 10/20 | 0.45 |
| ▸ | F2RL3 | Q96RI0 | 1/20 | 0.40 |
| ▸ | GHSR | Q92847 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | NPC1 | O15118 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | GLA | P06280 | 1/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.38 |
| ▸ | PTGS1 | P23219 | 4/20 | 0.38 |
| ▸ | DYRK1B | Q9Y463 | 1/20 | 0.38 |
| ▸ | CDK5 | Q00535 | 2/20 | 0.37 |
| ▸ | CDK5R1 | Q15078 | 2/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1304283 | 0.84 | PTGS2 (0.41) | PTGS2HDAC6PTGS1DYRK1B | |
| SCHEMBL4460450 | 0.79 | PTGS2 (0.44) | PTGS2GHSRPTGS1 | |
| SCHEMBL3291212 | 0.76 | PTGS2 (0.40) | PTGS2NPC1RAB9APTGS1DYRK1B | |
| SCHEMBL17998755 | 0.75 | DYRK1B (0.45) | PTGS2HDAC6PTGS1DYRK1B | |
| SCHEMBL7488038 | 0.71 | PTGS2 (0.52) | PTGS2PTGS1 | |
| SCHEMBL4464239 | 0.70 | RAB9A (0.39) | NPC1ALDH1A1RAB9A | |
| SCHEMBL7089059 | 0.69 | PTGS2 (0.65) | PTGS2ALDH1A1PTGS1 | |
| SCHEMBL5522736 | 0.67 | PTGS2 (0.70) | PTGS2GHSRPTGS1 | |
| SCHEMBL28451087 | 0.66 | SMN1; SMN2 (0.36) | KDM4ENPC1ALDH1A1RAB9A | |
| SCHEMBL791548 | 0.66 | PTGS2 (0.56) | PTGS2PTGS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1211244-A2 | 4,5-substitued imidazolyl compounds for the treatment of inflammation | G.D. Searle & Co. (US) | 2002-06-05 | — | — | EP | disclosed |